zur Startseite


Veranstalter, Ort

Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).

Laribi K, Poulain S, Willems L, Merabet F, Le Calloch R, Eveillard JR, Herbaux C, Roos-Weil D, Chaoui D, Roussel X, Tricot S, Dupuis J, Dartigeas C, Bareau B, Bene MC, Baugier de Materre A, Leblond V.
read more ›

How I treat rituximab refractory patients with WM.

Gavriatopoulou M, Ntanasis-Stathopoulos I, Kastritis E, Dimopoulos MA.
read more ›




Prof. Dr. C. Buske
Comprehensive Cancer Center Ulm
Institute of Experimental Cancer Research
University Hospital Ulm

89081 Ulm/Germany





phone:  +49-731-500 65 801
fax:        +49-731-500 65 822


Content responsible person in accordance to § 5 TMG and § 55 Abs. 2 RStV:
Prof. Dr. C. Buske (address as above)


Liability Note
Despite careful control we assume no liability for the content of external links. The content of the linked pages is the site operator’s responsibility.
All images, logos and texts on these sites are property of “Comprehensive Cancer Center Ulm” and their partners. The reproduction and/or proliferation of the given content in any form require the written approval of “Comprehensive Cancer Center Ulm”.


MJU.media Internetlösungen (www.mju-media.de)